Literature DB >> 196069

Antiproliferative activity of anti-inflammatory drugs in two mammalian cell culture lines.

V Hial, M C De Mello, Z Horakova, M A Beaven.   

Abstract

The nonsteroid anti-inflammatory drugs inhibited cell proliferation when added to rat hepatoma and human fibroblast cultures. The inhibition was reversible; normal growth resumed when the cultures were washed free of drug. Protein and nucleic acid synthesis, as measured by isotope incorporation was also reduced, although this reduction was probably a reflection of the decrease in cell numbers. An exception was that, in low concentration, the salicylate drugs, salicylamide, salicylic acid and aspirin, stimulated protein and nucleic acid synthesis, but in high concentrations (greater than 1 mM) they inhibited culture growth as well as protein and nucleic acid synthesis. Pharmacologically inactive derivatives, such as m-hydroxybenzoic acid and gentisic acid, were not inhibitory in concentrations up to 5 mM. The order of potency in inhibiting culture growth, meclofenamate greater than indomethacin greater than salicylamide greater than phenylbutazone greater than phenacetin greater than aspirin = salicylic acid, was similar to that reported for their anti-inflammator activity and their ability to inhibit prostaglandin synthesis. The antiproliferative activity of these drugs may, in part, account for their anti-inflammatory and toxic actions in vivo.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 196069

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  17 in total

1.  Effects of sulindac on sporadic colorectal adenomatous polyps.

Authors:  N Matsuhashi; A Nakajima; Y Fukushima; Y Yazaki; T Oka
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  Calcium salicylate-mediated apoptosis in human HT-1080 fibrosarcoma cells.

Authors:  J G Mahdi; M A Alkarrawi; A J Mahdi; I D Bowen; D Humam
Journal:  Cell Prolif       Date:  2006-08       Impact factor: 6.831

3.  Effects of D-penicillamine on growth and cell cycle kinetics of cultured rabbit articular chondrocytes.

Authors:  P Jaffray; X Ronot; M Adolphe; J Fontagne; P Lechat
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

4.  Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac.

Authors:  J J Keller; G J Offerhaus; M Polak; S N Goodman; M L Zahurak; L M Hylind; S R Hamilton; F M Giardiello
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

5.  Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis.

Authors:  F M Giardiello; E W Spannhake; R N DuBois; L M Hylind; C R Robinson; W C Hubbard; S R Hamilton; V W Yang
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

6.  In vitro effects of eicosanoid synthesis inhibitors in the presence of linoleic acid on MDA-MB-231 human breast cancer cells.

Authors:  M Earashi; M Noguchi; M Tanaka
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  Incorporation of fatty acids into phospholipids in L cells stimulated by antibody.

Authors:  W T Shearer; R G Ulrich
Journal:  Lipids       Date:  1984-04       Impact factor: 1.880

8.  Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells.

Authors:  S J Shiff; L Qiao; L L Tsai; B Rigas
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Effect of aspirin on mitochondrial mutagens in Saccharomyces cerevisiae.

Authors:  I J Bruce; D Wilkie
Journal:  Mol Gen Genet       Date:  1984

10.  Growth inhibition of transplantable murine colon adenocarcinoma 38 by indomethacin.

Authors:  M Sato; T Narisawa; M Sano; T Takahashi; A Goto
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.